India, Oct. 26 -- Shares of several biotech companies moved sharply higher following corporate and clinical developments. Surgery Partners surged on reports of a late-stage buyout talks with Bon Secours Mercy Health, Xencor rallied on updated Phase 1 data for XmAb819 in kidney cancer, Oruka Therapeutics jumped after strong Phase 2b psoriasis results for ORKA-001, and Acumen Pharmaceuticals traded actively ahead of November topline data from its Phase 2 Alzheimer's trial.
Read on.....
Surgery Partners, Inc. (SGRY)
Shares of Surgery Partners surged over 48% on Monday following reports that Bon Secours Mercy Health was in late-stage talks to acquire a majority stake in the outpatient surgery provider in a deal valued at approximately $6 bil...